Tramadol News and Research

RSS
Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Study sheds new light on potential habit-forming properties of tramadol

Study sheds new light on potential habit-forming properties of tramadol

Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain: an interview with Professor Sally Lawson

Rapid test to identify patients not responding to painkiller tramadol

Rapid test to identify patients not responding to painkiller tramadol

Simple blood test can quickly identify 'poor metabolisers'

Simple blood test can quickly identify 'poor metabolisers'

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

FDA approves Cipher’s Absorica to treat severe recalcitrant nodular acne

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Ampio submits pre-IND package on Zertane to FDA

Ampio submits pre-IND package on Zertane to FDA

ASN participates in ABIM Foundation's Choosing Wisely campaign

ASN participates in ABIM Foundation's Choosing Wisely campaign

Ampio, Australian TGA reach agreement over Zertane submission plan

Ampio, Australian TGA reach agreement over Zertane submission plan

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New ACR guidelines recommend use of topical NSAIDs for older patients with knee OA

New NPS information on dextropropoxyphene: recommendations and alternatives

New NPS information on dextropropoxyphene: recommendations and alternatives

Ampio announces two new European patents for Zertane combination therapy

Ampio announces two new European patents for Zertane combination therapy

Medical websites provide harmful information about postherpetic neuralgia treatments

Medical websites provide harmful information about postherpetic neuralgia treatments

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Cipher net revenue decreases to $0.7 million for Q2 2011

Cipher net revenue decreases to $0.7 million for Q2 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Top-line results from Cipher's CIP-ISOTRETINOIN Phase III study against severe nodular acne

Top-line results from Cipher's CIP-ISOTRETINOIN Phase III study against severe nodular acne

Cipher first quarter net revenue decreases to $0.7 million

Cipher first quarter net revenue decreases to $0.7 million

Labopharm first quarter total revenue increases to $5.3 million

Labopharm first quarter total revenue increases to $5.3 million